- Home
- MODD vs XCUR Comparison
MODD vs XCUR Comparison
Compare MODD & XCUR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
HOLD
Current Price
$0.16
HOLD
Current Price
$3.66
Company Overview
Basic Information| Metric | MODD | XCUR |
|---|---|---|
| Founded | 1998 | 2011 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Industrial Specialties | Biotechnology: Pharmaceutical Preparations |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 33.3M | 26.6M |
| IPO Year | 2019 | 2017 |
Fundamental Metrics
Financial Performance| Metric | MODD | XCUR |
|---|---|---|
| Price | $0.16 | $3.66 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 544.8K | 21.3K |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 34.62 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | ★ $500,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.15 | $3.10 |
| 52 Week High | $1.29 | $15.87 |
Technical Indicators
Market Signals| Indicator | MODD | XCUR |
|---|---|---|
| Relative Strength Index (RSI) | 18.86 | 37.86 |
| Support Level | N/A | $3.47 |
| Resistance Level | $0.49 | $4.23 |
| Average True Range (ATR) | 0.07 | 0.26 |
| MACD | -0.04 | 0.04 |
| Stochastic Oscillator | 9.32 | 19.80 |
Price Performance
Historical Comparison MODD
XCUR
About MODD Modular Medical Inc.
Modular Medical Inc is a development stage medical device company which focuses on the design, development, and commercialization of insulin pumps using modernized technology to increase pump adoption in the diabetes marketplace. The company's products seek to serve both the type 1 and the rapidly growing, especially in terms of device adoption, type 2 diabetes markets.
About XCUR Exicure Inc.
Exicure Inc is an early-stage biotechnology company focused on developing nucleic acid therapies targeting ribonucleic acid against validated targets. It operates in a single segment which is Biotechnology.